symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
BFRI,4.83,0,13900,6605653,0,4.74-25.8,-0.58,Biofrontera Inc.,USD,0001858685,US09077D1000,09077D100,NASDAQ Capital Market,NASDAQ,Drug Manufacturersâ€”Specialty & Generic,https://www.biofrontera.us.com,"Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.",Dr. Hermann  Luebbert Ph.D.,Healthcare,US,81,781 245 1325,120 Presidential Way,Woburn,MA,01801,,0,https://financialmodelingprep.com/image-stock/BFRI.png,2021-10-29,False,False,True,False,False
